Your browser doesn't support javascript.
loading
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study.
Lai, W Victoria; Lebas, Louisiane; Barnes, Tristan A; Milia, Julie; Ni, Ai; Gautschi, Oliver; Peters, Solange; Ferrara, Roberto; Plodkowski, Andrew J; Kavanagh, John; Sabari, Joshua K; Clarke, Stephen J; Pavlakis, Nick; Drilon, Alexander; Rudin, Charles M; Arcila, Maria E; Leighl, Natasha B; Shepherd, Frances A; Kris, Mark G; Mazières, Julien; Li, Bob T.
Afiliación
  • Lai WV; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lebas L; Toulouse University Hospital, Toulouse, France.
  • Barnes TA; Princess Margaret Cancer Centre, Toronto, Canada(2); Northern Beaches Cancer Service, Manly NSW Australia(3).
  • Milia J; Toulouse University Hospital, Toulouse, France.
  • Ni A; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gautschi O; Lucerne Cantonal Hospital, Lucerne, Switzerland.
  • Peters S; Lausanne University Hospital, Lausanne, Switzerland.
  • Ferrara R; Gustave Roussy, Villejuif, France.
  • Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kavanagh J; Toronto General Hospital, University Health Network and University of Toronto, Toronto, Canada.
  • Sabari JK; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; New York University Langone Health, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA(3).
  • Clarke SJ; Royal North Shore Hospital, University of Sydney, Sydney, Australia.
  • Pavlakis N; Royal North Shore Hospital, University of Sydney, Sydney, Australia.
  • Drilon A; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rudin CM; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Arcila ME; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Leighl NB; Princess Margaret Cancer Centre, Toronto, Canada(2).
  • Shepherd FA; Princess Margaret Cancer Centre, Toronto, Canada(2).
  • Kris MG; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mazières J; Toulouse University Hospital, Toulouse, France.
  • Li BT; Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: lib1@mskcc.org.
Eur J Cancer ; 109: 28-35, 2019 03.
Article en En | MEDLINE | ID: mdl-30685684
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Adenocarcinoma del Pulmón / Afatinib / Neoplasias Pulmonares / Mutación / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Adenocarcinoma del Pulmón / Afatinib / Neoplasias Pulmonares / Mutación / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos